|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/713 | (2006.01) |
| A61K 38/17 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| G01N 33/50 | (2006.01) | ||
| G01N 33/574 | (2006.01) |
| (11) | Number of the document | 2397156 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11162681.8 |
| Date of filing the European patent application | 2006-06-08 | |
| (97) | Date of publication of the European application | 2011-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-02 |
| (46) | Date of publication of the claims translation | 2017-02-27 |
| (30) | Number | Date | Country code |
| 688872 P | 2005-06-08 | US |
| (72) |
Barber, Daniel, US
Wherry, E. John, US
Freeman, Gordan, US
Sharpe, Arlene, US
Dorfman, David M., US
Ahmed, Rafi, US
|
| (73) |
The President and Fellows of Harvard College,
17 Quincy Street, Cambridge, MA 02138,
US
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215, US The Brigham and Women`s Hospital, Inc., 75 Francis Street, Boston, MA 02115, US Emory University, 1599 Clifton Road NE 4th Floor, Atlanta, GA 30322, US |
| (74) |
Ramunė GARŠVIENĖ,
Dūkštų g. 28-20, LT-07171 Vilnius,
LT
|
| (54) | Būdai ir kompozicijos, skirti nuolatinių infekcijų ir vėžio gydymui inhibuojant užprogramuotos ląstelės mirties-1 (PD-1) kelią |
| Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1)pathway |
| Payment date | Validity (years) | Amount | |
| 2024-05-20 | 19 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2023-12-26 |